233 filings
6-K
CYBN
Cybin Inc.
25 Apr 24
Cybin to Participate at the 27th Annual Milken Institute Global Conference
3:19pm
D
CYBN
Cybin Inc.
22 Apr 24
$1.90 mm in options, 17 investors
10:45am
6-K
CYBN
Cybin Inc.
18 Apr 24
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
3:12pm
6-K
CYBN
Cybin Inc.
18 Apr 24
Current report (foreign)
9:03am
SUPPL
CYBN
Cybin Inc.
18 Apr 24
Supplemental materials (foreign)
8:50am
6-K
2ho9w7s lz5
16 Apr 24
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
3:36pm
F-10POS
yt4 bmae074au
10 Apr 24
Automatic registration of securities (post-effective amendment, Canada)
8:35pm
6-K
q6anou nrwx4jix
10 Apr 24
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
5:23pm
D
jkjzb j0ycyligfp
3 Apr 24
$108.70 mm in equity, sold $108.70 mm, 12 investors
1:08pm
6-K
z2b2r
22 Mar 24
Material Change Report
2:41pm
6-K
ukrr34y8
21 Mar 24
Current report (foreign)
1:55pm
6-K
u2l48dag5sk1pvo9pq
20 Mar 24
Announces Oversubscribed Private Placement of U.S. $150 Million
3:16pm
6-K
wybs8kqe
18 Mar 24
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas
2:49pm
6-K
0plkl0q22
15 Mar 24
Current report (foreign)
3:19pm
6-K
y0jjqh
14 Mar 24
Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design
3:59pm
6-K
xfv85j
13 Mar 24
Current report (foreign)
4:09pm
6-K
678k3x dy38kdgsh9qr
13 Mar 24
Cybin to Host Conference Call and Webcast to Provide Program Update for CYB003
3:38pm
6-K
44me5a lml7i
27 Feb 24
Cybin to Present at the TD Cowen 44th Annual Health Care Conference
1:34pm
6-K/A
5ql54hntdu0
15 Feb 24
Condensed Interim Consolidated Financial Statements
11:09am
6-K
3iaf2 w3vwsx3mpyy2j
14 Feb 24
Condensed Interim Consolidated Financial Statements
8:17am